Gabriella Dobrowolny

Dr. Gabriella Dobrowolny

Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Sapienza University of Rome, 00161 Roma, Italy
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2001 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
Antonio MusaròAntonio Musarò
Antonio Musarò
KMKarl McCullagh
Karl McCullagh
APAngelika Paul
Angelika Paul
LHLeslie Houghton
Leslie Houghton
Gabriella DobrowolnyGabriella Dobrowolny
Gabriella Dobrowolny
NRNadia A. Rosenthal
Nadia A. Rosenthal

1 November 2008 in Cell Metabolism
Verified
Journal Article
Closed access
Gabriella DobrowolnyGabriella Dobrowolny
Gabriella Dobrowolny
MAMichela Aucello
Michela Aucello
Emanuele RizzutoEmanuele Rizzuto
Emanuele Rizzuto
SBSara Beccafico
Sara Beccafico
CMCristina Mammucari
Cristina Mammucari
Antonio MusaròAntonio Musarò
Antonio Musarò

17 January 2005 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
Gabriella DobrowolnyGabriella Dobrowolny
Gabriella Dobrowolny
CGCristina Giacinti
Cristina Giacinti
LPLaura Pelosi
Laura Pelosi
CNCarmine Nicoletti
Carmine Nicoletti
NWNadine Winn
Nadine Winn
Antonio MusaròAntonio Musarò
Antonio Musarò
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by a selective degeneration of motor neurons, atrophy, and paralysis of skeletal muscle. Although a significant proportion of familial ALS results from a toxic gain of function associated with dominant SOD1 mutations, the etiology of the disease and its specific cellular origins have remained difficult to define. Here, we show that muscle-restricted expression of a localized insulin-like growth factor (Igf) -1 isoform maintained muscle integrity and enhanced satellite cell activity in SOD1G93A transgenic mice, inducing calcineurin-mediated regenerative pathways. Muscle-specific expression of local Igf-1 (mIgf-1) isoform also stabilized neuromuscular junctions, reduced inflammation in the spinal cord, and enhanced motor neuronal survival in SOD1G93A mice, delaying the onset and progression of the disease. These studies establish skeletal muscle as a primary target for the dominant action of inherited SOD1 mutation and suggest that muscle fibers provide appropriate factors, such as mIgf-1, for neuron survival.

5 April 2019 in Aging Cell
Verified
Journal Article
Open access
PDF file
FAFrancesca Ascenzi
Francesca Ascenzi
LBLaura Barberi
Laura Barberi
Gabriella DobrowolnyGabriella Dobrowolny
Gabriella Dobrowolny
ABAline Villa Nova Bacurau
Aline Villa Nova Bacurau
CNCarmine Nicoletti
Carmine Nicoletti
Antonio MusaròAntonio Musarò
Antonio Musarò
The decline in skeletal muscle mass and strength occurring in aging, referred as sarcopenia, is the result of many factors including an imbalance between protein synthesis and degradation, changes in metabolic/hormonal status, and in circulating levels of inflammatory mediators. Thus, factors that increase muscle mass and promote anabolic pathways might be of therapeutic benefit to counteract sarcopenia. Among these, the insulin‐like growth factor‐1 (IGF‐1) has been implicated in many anabolic pathways in skeletal muscle. IGF‐1 exists in different isoforms that might exert different role in skeletal muscle. Here we study the effects of two full propeptides IGF‐1Ea and IGF‐1Eb in skeletal muscle, with the aim to define whether and through which mechanisms their overexpression impacts muscle aging. We report that only IGF‐1Ea expression promotes a pronounced hypertrophic phenotype in young mice, which is maintained in aged mice. Nevertheless, examination of aged transgenic mice revealed that the local expression of either IGF‐1Ea or IGF‐1Eb transgenes was protective against age‐related loss of muscle mass and force. At molecular level, both isoforms activate the autophagy/lysosome system, normally altered during aging, and increase PGC1‐α expression, modulating mitochondrial function, ROS detoxification, and the basal inflammatory state occurring at old age. Moreover, morphological integrity of neuromuscular junctions was maintained and preserved in both MLC/IGF‐1Ea and MLC/IGF‐1Eb mice during aging. These data suggest that IGF‐1 is a promising therapeutic agent in staving off advancing muscle weakness.

26 January 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Antonio MusaròAntonio Musarò
Antonio Musarò
CGCristina Giacinti
Cristina Giacinti
GBGiovanna Borsellino
Giovanna Borsellino
Gabriella DobrowolnyGabriella Dobrowolny
Gabriella Dobrowolny
LPLaura Pelosi
Laura Pelosi
NRNadia A. Rosenthal
Nadia A. Rosenthal
We investigated the mechanism whereby expression of a transgene encoding a locally acting isoform of insulin-like growth factor 1 (mIGF-1) enhances repair of skeletal muscle damage. Increased recruitment of proliferating bone marrow cells to injured MLC / mIgf-1 transgenic muscles was accompanied by elevated bone marrow stem cell production in response to distal trauma. Regenerating MLC / mIgf-1 transgenic muscles contained increased cell populations expressing stem cell markers, exhibited accelerated myogenic differentiation, expressed markers of regeneration and readily converted cocultured bone marrow to muscle. These data implicate mIGF-1 as a powerful enhancer of the regeneration response, mediating the recruitment of bone marrow cells to sites of tissue damage and augmenting local repair mechanisms.

28 March 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DSDorianna Sandonà
Dorianna Sandonà
JDJean-François Desaphy
Jean-François Desaphy
GCGiulia M. Camerino
Giulia M. Camerino
EBElisa Bianchini
Elisa Bianchini
Stefano CiciliotStefano Ciciliot
Stefano Ciciliot
SSStefano Schiaffino
Stefano Schiaffino
The effect of microgravity on skeletal muscles has so far been examined in rat and mice only after short-term (5–20 day) spaceflights. The mice drawer system (MDS) program, sponsored by Italian Space Agency, for the first time aimed to investigate the consequences of long-term (91 days) exposure to microgravity in mice within the International Space Station. Muscle atrophy was present indistinctly in all fiber types of the slow-twitch soleus muscle, but was only slightly greater than that observed after 20 days of spaceflight. Myosin heavy chain analysis indicated a concomitant slow-to-fast transition of soleus. In addition, spaceflight induced translocation of sarcolemmal nitric oxide synthase-1 (NOS1) into the cytosol in soleus but not in the fast-twitch extensor digitorum longus (EDL) muscle. Most of the sarcolemmal ion channel subunits were up-regulated, more in soleus than EDL, whereas Ca2+-activated K+ channels were down-regulated, consistent with the phenotype transition. Gene expression of the atrophy-related ubiquitin-ligases was up-regulated in both spaceflown soleus and EDL muscles, whereas autophagy genes were in the control range. Muscle-specific IGF-1 and interleukin-6 were down-regulated in soleus but up-regulated in EDL. Also, various stress-related genes were up-regulated in spaceflown EDL, not in soleus. Altogether, these results suggest that EDL muscle may resist to microgravity-induced atrophy by activating compensatory and protective pathways. Our study shows the extended sensitivity of antigravity soleus muscle after prolonged exposition to microgravity, suggests possible mechanisms accounting for the resistance of EDL, and individuates some molecular targets for the development of countermeasures.